Systematic adjudication of myocardial infarction end-points in an international clinical trial

被引：0
|
作者：
Kenneth W Mahaffey
Robert A Harrington
Martijn Akkerhuis
Neal S Kleiman
Lisa G Berdan
Brian S Crenshaw
Barbara E Tardiff
Christopher B Granger
Ingrid DeJong
Manju Bhapkar
Petr Widimsky
Ramón Corbalon
Kerry L Lee
Jaap W Deckers
Maarten L Simoons
Eric J Topol
Robert M Califf
机构：
[1] Duke Clinical Research Institute,
[2] Thoraxcenter,undefined
[3] Erasmus University,undefined
[4] Baylor College of Medicine and the Methodist Hospital,undefined
[5] University Hospital Vinohrady,undefined
[6] University Catolica,undefined
[7] The Cleveland Clinic Foundation,undefined
来源：
Trials | / 2卷 / 4期
关键词：
acute coronary syndromes; adjudication; clinical events committee; clinical trials; myocardial infarction;
D O I：
10.1186/cvm-2-4-180
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Progress Towards Optimal Trial End-Points in Rheumatoid Arthritis
    Maarten Boers
    Peter Tugwell
    Peter M. Brooks
    BioDrugs, 1997, 7 : 40 - 50
  • [22] Progress towards optimal trial end-points in rheumatoid arthritis
    Boers, M
    Tugwell, P
    Brooks, PM
    BIODRUGS, 1997, 7 (01) : 40 - 50
  • [23] TRIAL OBJECTIVES AND END-POINTS FOR MEASURING THE EFFICACY OF HIV VACCINES
    HOFF, R
    BARKER, LF
    INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY, 1995, 4 (02): : 95 - 101
  • [24] TRIAL DESIGN ISSUES - END-POINTS AND SAMPLE-SIZE
    BRASS, LM
    CEREBROVASCULAR DISEASES, 1995, 5 : 3 - 11
  • [25] End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?
    Peacock, A. J.
    Naeije, R.
    Galie, N.
    Rubin, L.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (01) : 231 - 242
  • [26] CURRENT DEFINITIONS OF PERIPROCEDURAL MYOCARDIAL INFARCTION ARE NOT SURROGATE MARKERS FOR CATHETERIZATION LAB QUALITY OR CLINICAL TRIAL END POINTS
    Baker, Nevin
    Alarcon, Ricardo Escarcega
    Lipinski, Michael
    Minha, Sa'ar
    Pereira, Marco Magalhaes
    Loh, Joshua
    Pendyala, Lakshmana
    Omar, Alfazir
    Hideaki, Ota
    Torguson, Rebecca
    Chen, Fang
    Suddath, William
    Satler, Lowell
    Pichard, Augusto
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A19 - A19
  • [27] MULTIVARIATE TESTS FOR MULTIPLE END-POINTS IN CLINICAL-TRIALS
    FOLLMANN, D
    STATISTICS IN MEDICINE, 1995, 14 (11) : 1163 - 1175
  • [28] THIOPENTAL OR PROPOFOL INTERACTIONS WITH MIDAZOLAM - CLINICAL AND EEG END-POINTS
    WILDERSMITH, OHG
    DESPLAND, PA
    BETTEX, D
    DECOSTERD, LA
    RAVUSSIN, PA
    ANESTHESIOLOGY, 1995, 83 (3A) : A368 - A368
  • [29] IMPACT OF PROGNOSTIC FACTORS ON END-POINTS FOR CLINICAL-STUDIES
    SORENSEN, JB
    LUNG CANCER, 1994, 11 : S45 - S54
  • [30] DESIGN OF CLINICAL-TRIALS - END-POINTS - OPEN DISCUSSION
    ELLENBERG, S
    BROWN, L
    MILLS, J
    MOSS, A
    BYAR, D
    SHEINER, L
    LAGAKOS, S
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1990, 3 : S75 - S76
12345